Literature DB >> 2476033

The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution.

B C Wolf1, R R Salem, H F Sears, D A Horst, P T Lavin, M Herlyn, S H Itzkowitz, J Schlom, G D Steele.   

Abstract

Immunohistologic studies were performed to evaluate the expression and regional distribution of 20 colorectal carcinoma-associated antigens in the colonic mucosa of 12 normal adults. A distinct regional variation was seen in the expression of blood group A, B, Lewis(b), and extended Lewis(y) antigens, which were expressed predominantly in the right colon, whereas Lewis(a), Lewis(y), and H-type 2 were prevalent throughout. Lewis(x) and X-like antigens were only occasionally expressed. Two antibodies against sialylated Lewis(a) showed different staining patterns, with CA19.9 positive in only two biopsies and CO29.11 intensely positive in most. Two of the three antibodies detecting carcinoembryonic antigen epitopes (3d6 and COL-4) stained many biopsies, whereas COL-12 was rarely detected. No regional gradient was found in the expression of the other antigens studied (B72.3, ME491; GA73.3, ND1, and ND4). This mapping data will provide an important baseline for future studies of epitope distribution in the colon in premalignant and neoplastic conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476033      PMCID: PMC1880239     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Carcinoembryonic antigen and blood group substances in carcinomas of the stomach and colon.

Authors:  H Denk; G Tappeiner; A Davidovits; R Eckerstorfer; J H Holzner
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

2.  Immunologic diagnosis and prognosis of human digestive-tract cancer: carcinoembryonic antigens.

Authors:  N Zamcheck; T L Moore; P Dhar; H Kupchik
Journal:  N Engl J Med       Date:  1972-01-13       Impact factor: 91.245

3.  Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.

Authors:  H J Wanebo; B Rao; C M Pinsky; R G Hoffman; M Stearns; M K Schwartz; H F Oettgen
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

4.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

5.  A cell surface glycoprotein expressed by colorectal carcinomas including poorly differentiated, noncarcinoembryonic antigen-producing colorectal tumors.

Authors:  R R Salem; B C Wolf; H F Sears; P Thomas; B Bollinger; N Zamcheck; C A Saravis; L B Chen; G Steele
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

Review 6.  The present status of DEA in diagnosis, prognosis, and evaluation of therapy.

Authors:  N Zamcheck
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

7.  Immunohistologic study of blood group substances in polyps of the distal colon. Expression of a fetal antigen.

Authors:  H S Cooper; J Cox; A S Patchefsky
Journal:  Am J Clin Pathol       Date:  1980-03       Impact factor: 2.493

8.  Blood group substances as tumor antigens in the distal colon.

Authors:  H S Cooper; W E Haesler
Journal:  Am J Clin Pathol       Date:  1978-06       Impact factor: 2.493

9.  Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon.

Authors:  E L Wiley; G Mendelsohn; J C Eggleston
Journal:  Lab Invest       Date:  1981-06       Impact factor: 5.662

10.  Alterations of membrane glycopeptides in human colonic adenocarcinoma.

Authors:  Y S Kim; R Isaacs; J M Perdomo
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

View more
  9 in total

1.  Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins.

Authors:  T Sata; J Roth; C Zuber; B Stamm; P U Heitz
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

2.  SSO Clinical Award Lecture. The surgical oncologist as a key translator of basic biology to patients with gastrointestinal cancer: asking the right questions.

Authors:  G Steele
Journal:  Ann Surg Oncol       Date:  1994-05       Impact factor: 5.344

3.  Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis.

Authors:  F Guadagni; P Graziano; M Roselli; S Mariotti; P Bernard; P Sinibaldi-Vallebona; G Rasi; E Garaci
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

4.  Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.

Authors:  K Irvine; J Schlom
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

5.  Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering.

Authors:  J Xiang; J Koropatnick; Y Qi; X Luo; T Moyana; K Li; Y Chen
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  Autologous human B-cell immune response to pulmonary adenocarcinomatous polymorphic epithelial mucin.

Authors:  J Xiang; T Moyana; A Maksymiuk
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

7.  Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.

Authors:  J M Bae; J H Kim; N-Y Cho; T-Y Kim; G H Kang
Journal:  Br J Cancer       Date:  2013-07-30       Impact factor: 7.640

Review 8.  Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.

Authors:  Marco Trinchera; Adele Aronica; Fabio Dall'Olio
Journal:  Biology (Basel)       Date:  2017-02-23

9.  Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies.

Authors:  P J Hertzog; S J Pilbrow; J Pedersen; A L Polglase; M Lawson; A W Linnane
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.